Committed to responsible pain management

Developing innovative and differentiated products for people suffering from pain

At Collegium Pharmaceutical we are committed to being the leader in responsible pain management. We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate to severe pain.

News and Press

Join the Collegium team

See Job Listings

News and Press

  • Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million

    Read More
  • Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and Provide Corporate Update

    Read More
  • Collegium Provides 2021 Financial Guidance

    Read More
  • Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020

    Read More